Filing Details

Accession Number:
0001144204-16-087144
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-10 14:08:47
Reporting Period:
2016-03-09
Filing Date:
2016-03-10
Accepted Time:
2016-03-10 14:08:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488039 Atossa Genetics Inc ATOS Surgical & Medical Instruments & Apparatus (3841) 264753208
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1552127 Shu-Chih Chen C/O Atossa Genetics, Inc.
2300 Eastlake Ave. East, Suite 200
Seattle WA 98102
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-09 15,000 $0.37 4,348,315 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. Represents 15,000 shares purchased in an at-market transaction directly from Atossa Genetics, Inc.
  2. Consists of 4,348,315 shares of common stock owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity.